A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced Non-Small Cell Lung Cancer (NSCLC)

http://isrctn.org/> ◽

10.1186/isrctn77341241 ◽

2012 ◽

Author(s):

Siow Ming Lee

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7631 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7631-7631 ◽

Author(s):

M. Schuster ◽

J. R. Rigas ◽

S. V. Orlov ◽

B. Milovanovic ◽

K. Prabhash ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Advances in Therapy ◽

10.1007/s12325-020-01538-0 ◽

2020 ◽

Author(s):

Lowell L. Hart ◽

Renata Ferrarotto ◽

Zoran G. Andric ◽

J. Thaddeus Beck ◽

Janakiraman Subramanian ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

C1-03: A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283190.70038.e9 ◽

2007 ◽

Vol 2 (8) ◽

pp. S359 ◽

Author(s):

Siow-Ming Lee ◽

Penella J. Woll ◽

Robin M. Rudd ◽

Nicole H. Gower ◽

Christian H. Ottensmeier ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-0483 ◽

2018 ◽

Vol 24 (17) ◽

pp. 4089-4097 ◽

Author(s):

Tadashi Akiba ◽

Toshiaki Morikawa ◽

Makoto Odaka ◽

Takeo Nakada ◽

Noriki Kamiya ◽

...

Keyword(s):

Lung Cancer ◽

Vitamin D ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Vitamin D Supplementation ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Abstract LB-77: A randomized double-blind placebo-controlled phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small cell lung cancer: Correlative analyses

10.1158/1538-7445.am10-lb-77 ◽

2010 ◽

Author(s):

David R. Spigel ◽

Howard A. Burris ◽

F. Anthony Greco ◽

Diana L. Shipley ◽

Elke K. Friedman ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Previously Treated

Download Full-text

Double blind, placebo controlled trial of oral lactoferrin in combination therapy for first line non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7141 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7141-7141

Author(s):

Y. Wang ◽

E. Yankee ◽

A. Varadhachary

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Randomized, double-blind, placebo-controlled trial of evofosfamide (Evo) and pemetrexed (Pem) in advanced non-squamous non-small cell lung cancer (n-s NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.9075 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 9075-9075

Author(s):

Tibor Csõszi ◽

Jonathan Wade Goldman ◽

Maria Szilasi ◽

Joachim Von Pawel ◽

Silvia Novello ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without thalidomide in small cell lung cancer

http://isrctn.org/> ◽

10.1186/isrctn16174527 ◽

2013 ◽

Author(s):

Siow Ming Lee

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Randomized, Double-Blind, Placebo-Controlled Trial of Evofosfamide (TH-302) in Combination with Pemetrexed in Advanced Non-Squamous Non-Small Cell Lung Cancer

Annals of Oncology ◽

10.1093/annonc/mdv050.46 ◽

2015 ◽

Vol 26 ◽

pp. i29 ◽

Author(s):

J. Goldman ◽

C. Belani ◽

S. Novello ◽

J. von Pawel ◽

T. Csoszi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Phase III randomized double blind placebo controlled trial of cisplatin(P) and etoposide (E) plus megestrol acetate (M)/placebo in extensive stage small cell lung cancer (SCLC)

Lung Cancer ◽

10.1016/0169-5002(94)94116-5 ◽

1994 ◽

Vol 11 ◽

pp. 90 ◽

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Extensive Stage

Download Full-text